Orlando, Florida
Alzheimer's disease clinical trials in Orlando, FL
19 Alzheimer's disease studies are recruiting participants at sites in Orlando as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Orlando at a glance
- 19 studies are recruiting at a site in Orlando.
- By phase: Phase 1 (1), Phase 1/2 (2), Phase 2 (6), Phase 2/3 (1), Phase 3 (6), No phase (1), Observational (2). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (18), university, hospital or other (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Orlando
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study sites
- Charter Research - Winter Park/Orlando · Conquest Research - Lake Nona
- Registry record
- NCT07177352 · updated
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study sites
- Combined Research Orlando Phase I-IV LLC · Nova Psychiatry
- Registry record
- NCT05980949 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Combined Research Orlando (CRO)
- Registry record
- NCT07011732 · updated
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Sanofi
- Study site
- K2 Medical Research - Orlando - South Orlando Avenue- Site Number : 8400008
- Registry record
- NCT07688213 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study sites
- Charter Research - Winter Park/Orlando · Conquest Research - Lake Nona
- Registry record
- NCT07717411 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- Combined Research Orlando Phase I IV
- Registry record
- NCT06159673 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Charter Research - Orlando
- Registry record
- NCT07589595 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Charter Research
- Registry record
- NCT06651567 · updated
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
- Phase 1
- Ages 30 to 80
- All sexes
- Sponsor
- Voyager Therapeutics
- Study site
- AdventHealth Orlando
- Registry record
- NCT07764146 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Charter Research - Orlando · Headlands Research Orlando
- Registry record
- NCT07602582 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study sites
- Charter Research Orlando · Combined Research Orlando Phase I-IV LLC · Nova Psychiatry
- Registry record
- NCT06585787 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Charter Research - Orlando ( Site 1051)
- Registry record
- NCT07033494 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Study site
- Conquest Research - Lake Nona
- Registry record
- NCT06847321 · updated
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
- Phase 1/2
- Ages 40 to 85
- All sexes
- Sponsor
- NKGen Biotech, Inc.
- Study site
- AdventHealth Research Institute
- Registry record
- NCT06189963 · updated
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Phase 1/2
- Ages 35 to 85
- All sexes
- Sponsor
- AC Immune SA
- Study site
- Charter Research, LLC
- Registry record
- NCT05462106 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Study site
- Charter Research
- Registry record
- NCT06584357 · updated
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
- No phase
- Ages 50 to 85
- All sexes
- Sponsor
- InSightec
- Study site
- Advent Health
- Registry record
- NCT03671889 · updated
University of Central Florida CereBank
- Observational
- Ages 18 and older
- Female participants
- Sponsor
- University of Central Florida
- Study site
- University of Central Florida
- Registry record
- NCT06876857 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Orlando, FL on ClinicalTrials.gov.
Ask about studies near Orlando
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
61 studies recruiting across 50 cities.
Miami
24 studies recruiting.
Tampa
20 studies recruiting.
Maitland
19 studies recruiting.
Winter Park
11 studies recruiting.
Stuart
10 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections